Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check2 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and where to check status, and updated the page revision to v3.4.1 (removing v3.4.0).SummaryDifference0.5%

- Check9 days agoChange DetectedAdded a Show glossary option and a new 'Last Update Submitted that Met QC Criteria' field. Updated capitalization of 'Last Update Submitted that met QC Criteria', standardized 'No FEAR Act Data' wording, and bumped the revision from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page, reflecting a version bump. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded a California Locations section to list the site locations. Updated page revision to v3.3.3.SummaryDifference0.2%

- Check73 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the study's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedRemoved the notice that information may be outdated due to a lapse in government funding, including references to cc.nih.gov and opm.gov for operating status.SummaryDifference0.4%

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.